“Sensory Neuroimmune Signaling Opens a New Precision Medicine Window for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis”. 2026. Novera 1 (1). https://submit.noverapress.com/index.php/Novera/article/view/10.